JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M306755200 on September 17, 2003

J. Biol. Chem., Vol. 278, Issue 48, 48169-48177, November 28, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/48/48169    most recent
M306755200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hodder, A. N.
Right arrow Articles by Crabb, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hodder, A. N.
Right arrow Articles by Crabb, B. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Enzymic, Phylogenetic, and Structural Characterization of the Unusual Papain-like Protease Domain of Plasmodium falciparum SERA5*

Anthony N. Hodder,ab Damien R. Drew,ac V. Chandana Epa,d Mauro Delorenzi,ae Richard Bourgon,f Susanne K. Miller,ag Robert L. Moritz,h David F. Frecklington,h Richard J. Simpson,h Terence P. Speed,af Robert N. Pike,i and Brendan S. Crabbabj

From the aThe Walter and Eliza Hall Institute of Medical Research, Melbourne, 1G Royal Parade, Parkville, Victoria 3050, Australia, the dDivision of Health Sciences and Nutrition, Commonwealth Scientific and Industrial Research Organisation, Melbourne, Victoria 3052, Australia, the fDepartment of Statistics, University of California, Berkeley, California 94720, the hJoint Proteomics Laboratory, Ludwig Institute for Cancer Research and the Walter and Eliza Hall Institute of Medical Research, Melbourne 3052, Australia, and the iDepartment of Biochemistry and Molecular Biology, Monash University, Melbourne, Victoria 3800, Australia

Serine repeat antigen 5 (SERA5) is an abundant antigen of the human malaria parasite Plasmodium falciparum and is the most strongly expressed member of the nine-gene SERA family. It appears to be essential for the maintenance of the erythrocytic cycle, unlike a number of other members of this family, and has been implicated in parasite egress and/or erythrocyte invasion. All SERA proteins possess a central domain that has homology to papain except in the case of SERA5 (and some other SERAs), where the active site cysteine has been replaced with a serine. To investigate if this domain retains catalytic activity, we expressed, purified, and refolded a recombinant form of the SERA5 enzyme domain. This protein possessed chymotrypsin-like proteolytic activity as it processed substrates downstream of aromatic residues, and its activity was reversed by the serine protease inhibitor 3,4-diisocoumarin. Although all Plasmodium SERA enzyme domain sequences share considerable homology, phylogenetic studies revealed two distinct clusters across the genus, separated according to whether they possess an active site serine or cysteine. All Plasmodia appear to have at least one member of each group. Consistent with separate biological roles for members of these two clusters, molecular modeling studies revealed that SERA5 and SERA6 enzyme domains have dramatically different surface properties, although both have a characteristic papain-like fold, catalytic cleft, and an appropriately positioned catalytic triad. This study provides impetus for the examination of SERA5 as a target for antimalarial drug design.


Received for publication, June 25, 2003 , and in revised form, September 8, 2003.

* This work was supported in part by the National Health and Medical Research Council (NHMRC) of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

c A recipient of an NHMRC postdoctoral award (Peter Doherty).

e Present address: Swiss Institute for Experimental Cancer Research, CH-1066 Epalinges, Switzerland.

g A recipient of an Australian Postgraduate Research Award.

j An International Research Scholar of the Howard Hughes Medical Institute.

b To whom correspondence may be addressed. Tel.: 61-3-9345-2555; Fax: 61-3-9347-0852; E-mail: hodder{at}wehi.edu.au (A. N. H.) and crabb{at}wehi.edu.au (B. S. C.).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
W. D. Fairlie, T. P. Spurck, J. E. McCoubrie, P. R. Gilson, S. K. Miller, G. I. McFadden, R. Malby, B. S. Crabb, and A. N. Hodder
Inhibition of Malaria Parasite Development by a Cyclic Peptide That Targets the Vital Parasite Protein SERA5
Infect. Immun., September 1, 2008; 76(9): 4332 - 4344.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
C. Mendoza-Palomares, N. Biteau, C. Giroud, V. Coustou, T. Coetzer, E. Authie, A. Boulange, and T. Baltz
Molecular and Biochemical Characterization of a Cathepsin B-Like Protease Family Unique to Trypanosoma congolense
Eukaryot. Cell, April 1, 2008; 7(4): 684 - 697.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. E. McCoubrie, S. K. Miller, T. Sargeant, R. T. Good, A. N. Hodder, T. P. Speed, T. F. de Koning-Ward, and B. S. Crabb
Evidence for a Common Role for the Serine-Type Plasmodium falciparum Serine Repeat Antigen Proteases: Implications for Vaccine and Drug Design
Infect. Immun., December 1, 2007; 75(12): 5565 - 5574.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. R. Sanders, L. M. Kats, D. R. Drew, R. A. O'Donnell, M. O'Neill, A. G. Maier, R. L. Coppel, and B. S. Crabb
A Set of Glycosylphosphatidyl Inositol-Anchored Membrane Proteins of Plasmodium falciparum Is Refractory to Genetic Deletion
Infect. Immun., July 1, 2006; 74(7): 4330 - 4338.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
B. OKECH, G. MUJUZI, A. OGWAL, H. SHIRAI, T. HORII, and T. G. EGWANG
HIGH TITERS OF IgG ANTIBODIES AGAINST PLASMODIUM FALCIPARUM SERINE REPEAT ANTIGEN 5 (SERA5) ARE ASSOCIATED WITH PROTECTION AGAINST SEVERE MALARIA IN UGANDAN CHILDREN
Am J Trop Med Hyg, February 1, 2006; 74(2): 191 - 197.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. R. Sanders, P. R. Gilson, G. T. Cantin, D. C. Greenbaum, T. Nebl, D. J. Carucci, M. J. McConville, L. Schofield, A. N. Hodder, J. R. Yates III, et al.
Distinct Protein Classes Including Novel Merozoite Surface Antigens in Raft-like Membranes of Plasmodium falciparum
J. Biol. Chem., December 2, 2005; 280(48): 40169 - 40176.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. C. Pandey, S. X. Wang, P. S. Sijwali, A. L. Lau, J. H. McKerrow, and P. J. Rosenthal
The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif
PNAS, June 28, 2005; 102(26): 9138 - 9143.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
R. Bourgon, M. Delorenzi, T. Sargeant, A. N. Hodder, B. S. Crabb, and T. P. Speed
The Serine Repeat Antigen (SERA) Gene Family Phylogeny in Plasmodium: The Impact of GC Content and Reconciliation of Gene and Species Trees
Mol. Biol. Evol., November 1, 2004; 21(11): 2161 - 2171.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.